Potential value of tumor stiffness and sE-cadherin in predicting the response to neoadjuvant therapy in HER2-positive breast cancers

This prospective study compared the diagnostic value of tumor stiffness and serum soluble E-cadherin (sE-cadherin) expression for predicting response to neoadjuvant therapy in HER2-positive breast cancers. 112 patients with early or locally advanced HER2-positive breast cancer were enrolled. Maximum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future oncology (London, England) England), 2022-08, Vol.18 (25), p.2817-2825
Hauptverfasser: Zhou, Weixia, Wu, Meng, Lin, Hongxia, Chen, Wanjun, Lu, Guowen, Yang, Feibiao, Chen, Yaling, Chen, Gun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!